Just when you thought Bristol Myers Squibb had finished its epic game of corporate musical chairs, they've decided to pull out even more...

In what can only be described as a stunning display of pharmaceutical mismanagement, Lexicon Pharmaceuticals has managed to achieve what...

Takeda offered "limited details" on what its "efficiency program" would entail. The company said it would focus on "organizational...

Look, I'm not trying to pick on Pfizer here, but they keep giving me material that's impossible to ignore. And finally, someone with...

Bit delayed in posting this one, but here goes... In what feels like a corporate soap opera, Pfizer's latest episode with activist...

Is anyone else feeling a sense of déjà vu? Once again, we're witnessing a pharmaceutical giant fumble a multi-million dollar acquisition,...

Hey there, pharma fanatics! Buckle up, because we're about to take a wild ride through the twisty world of CAR-T therapy, where Bristol...

Hey there, pharma watchers! Grab your popcorn, because we've got a doozy of a story today. Remember when Pfizer splurged $5.4 billion to...